Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 30

    1.

    Panhypopituitarism due to Metastases to the Hypothalamus and the Pituitary Resulting From Primary Breast Cancer: A Case Report and Review of the Literature.

    Peppa M, Papaxoinis G, Xiros N, Raptis SA, Economopoulos T, Hadjidakis D.

    Clin Breast Cancer. 2009 Nov;9(4):E4-7.PMID: 19933072 [PubMed - in process]

    2.

    Dilated cardiomyopathy as the predominant feature of Cushing's syndrome.

    Peppa M, Ikonomidis I, Hadjidakis D, Pikounis V, Paraskevaidis I, Economopoulos T, Raptis SA, Kremastinos DT.

    Am J Med Sci. 2009 Sep;338(3):252-3.PMID: 19687733 [PubMed - indexed for MEDLINE]Related articles

    3.

    Advanced glycoxidation products and impaired diabetic wound healing.

    Peppa M, Stavroulakis P, Raptis SA.

    Wound Repair Regen. 2009 Jul-Aug;17(4):461-72. Review.PMID: 19614910 [PubMed - indexed for MEDLINE]Related articles

    4.

    Embolization as an alternative treatment of insulinoma in a patient with multiple endocrine neoplasia type 1 syndrome.

    Peppa M, Brountzos E, Economopoulos N, Boutati E, Pikounis V, Patapis P, Economopoulos T, Raptis SA, Hadjidakis D.

    Cardiovasc Intervent Radiol. 2009 Jul;32(4):807-11. Epub 2009 Jan 30.PMID: 19184198 [PubMed - in process]Related articles

    5.

    Studies of insulin resistance in patients with clinical and subclinical hypothyroidism.

    Maratou E, Hadjidakis DJ, Kollias A, Tsegka K, Peppa M, Alevizaki M, Mitrou P, Lambadiari V, Boutati E, Nikzas D, Tountas N, Economopoulos T, Raptis SA, Dimitriadis G.

    Eur J Endocrinol. 2009 May;160(5):785-90. Epub 2009 Jan 13.PMID: 19141606 [PubMed - indexed for MEDLINE]Related articles

    6.

    Multiple endocrine neoplasia type 2A in two families with the familial medullary thyroid carcinoma associated G533C mutation of the RET proto-oncogene.

    Peppa M, Boutati E, Kamakari S, Pikounis V, Peros G, Panayiotides IG, Economopoulos T, Raptis SA, Hadjidakis D.

    Eur J Endocrinol. 2008 Dec;159(6):767-71. Epub 2008 Sep 19. Review.PMID: 18805915 [PubMed - indexed for MEDLINE]Related articles

    7.

    Novel germline mutations of the MEN1 gene in Greek families with multiple endocrine neoplasia type 1.

    Peppa M, Boutati E, Kamakari S, Pikounis V, Peros G, Koutsodontis G, Metaxa-Mariatou V, Economopoulos T, Raptis SA, Hadjidakis D.

    Clin Endocrinol (Oxf). 2009 Jan;70(1):75-81. Epub 2008 Jun 12.PMID: 18549467 [PubMed - indexed for MEDLINE]Related articles

    8.

    Severity of coronary artery disease in postmenopausal diabetic women.

    Saltiki K, Cimponeriu A, Lili K, Peppa M, Anastasiou E, Alevizaki M.

    Hormones (Athens). 2008 Apr-Jun;7(2):148-55.PMID: 18477552 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Aging and glycoxidant stress.

    Peppa M, Uribarri J, Vlassara H.

    Hormones (Athens). 2008 Apr-Jun;7(2):123-32. Review.PMID: 18477549 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Advanced glycation end products and cardiovascular disease.

    Peppa M, Raptis SA.

    Curr Diabetes Rev. 2008 May;4(2):92-100. Review.PMID: 18473756 [PubMed - indexed for MEDLINE]Related articles

    11.

    IGF-I increases the recruitment of GLUT4 and GLUT3 glucose transporters on cell surface in hyperthyroidism.

    Dimitriadis G, Maratou E, Boutati E, Kollias A, Tsegka K, Alevizaki M, Peppa M, Raptis SA, Hadjidakis DJ.

    Eur J Endocrinol. 2008 Mar;158(3):361-6.PMID: 18299470 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Circulating glycotoxins and dietary advanced glycation endproducts: two links to inflammatory response, oxidative stress, and aging.

    Uribarri J, Cai W, Peppa M, Goodman S, Ferrucci L, Striker G, Vlassara H.

    J Gerontol A Biol Sci Med Sci. 2007 Apr;62(4):427-33.PMID: 17452738 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    The concurrence of microalbuminuria and retinopathy with cardiovascular risk factors; reliable predictors of asymptomatic coronary artery disease in type 2 diabetes.

    Ioannidis G, Peppa M, Rontogianni P, Callifronas M, Papadimitriou C, Chrysanthopoulou G, Anthopoulos L, Kesse M, Thalassinos N.

    Hormones (Athens). 2004 Jul-Sep;3(3):198-203.PMID: 16982593 [PubMed]Related articlesFree article

    14.

    Prevention and reversal of diabetic nephropathy in db/db mice treated with alagebrium (ALT-711).

    Peppa M, Brem H, Cai W, Zhang JG, Basgen J, Li Z, Vlassara H, Uribarri J.

    Am J Nephrol. 2006;26(5):430-6. Epub 2006 Sep 13.PMID: 16974073 [PubMed - indexed for MEDLINE]Related articles

    15.

    Association of advanced glycoxidation end products and inflammation markers with thrombosis of arteriovenous grafts in hemodialysis patients.

    Cai W, Zhu L, Chen X, Uribarri J, Peppa M.

    Am J Nephrol. 2006;26(2):181-5. Epub 2006 May 3.PMID: 16675897 [PubMed - indexed for MEDLINE]Related articles

    16.

    Advanced glycation end products and diabetic complications: a general overview.

    Peppa M, Vlassara H.

    Hormones (Athens). 2005 Jan-Mar;4(1):28-37. Review.PMID: 16574629 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Diet-derived advanced glycation end products are major contributors to the body's AGE pool and induce inflammation in healthy subjects.

    Uribarri J, Cai W, Sandu O, Peppa M, Goldberg T, Vlassara H.

    Ann N Y Acad Sci. 2005 Jun;1043:461-6. Review.PMID: 16037267 [PubMed - indexed for MEDLINE]Related articles

    18.

    Advanced glycoxidation end products in commonly consumed foods.

    Goldberg T, Cai W, Peppa M, Dardaine V, Baliga BS, Uribarri J, Vlassara H.

    J Am Diet Assoc. 2004 Aug;104(8):1287-91. Erratum in: J Am Diet Assoc. 2005 Apr;105(4):647. PMID: 15281050 [PubMed - indexed for MEDLINE]Related articles

    19.

    High levels of dietary advanced glycation end products transform low-density lipoprotein into a potent redox-sensitive mitogen-activated protein kinase stimulant in diabetic patients.

    Cai W, He JC, Zhu L, Peppa M, Lu C, Uribarri J, Vlassara H.

    Circulation. 2004 Jul 20;110(3):285-91. Epub 2004 Jul 12.PMID: 15249511 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Glycoxidation and inflammation in renal failure patients.

    Peppa M, Uribarri J, Cai W, Lu M, Vlassara H.

    Am J Kidney Dis. 2004 Apr;43(4):690-5.PMID: 15042546 [PubMed - indexed for MEDLINE]Related articles

    21.

    The role of advanced glycation end products in the development of atherosclerosis.

    Peppa M, Uribarri J, Vlassara H.

    Curr Diab Rep. 2004 Feb;4(1):31-6. Review.PMID: 14764277 [PubMed - indexed for MEDLINE]Related articles

    22.

    Adverse effects of dietary glycotoxins on wound healing in genetically diabetic mice.

    Peppa M, Brem H, Ehrlich P, Zhang JG, Cai W, Li Z, Croitoru A, Thung S, Vlassara H.

    Diabetes. 2003 Nov;52(11):2805-13.PMID: 14578300 [PubMed - indexed for MEDLINE]Related articlesFree article

    23.

    Dietary glycotoxins correlate with circulating advanced glycation end product levels in renal failure patients.

    Uribarri J, Peppa M, Cai W, Goldberg T, Lu M, Baliga S, Vassalotti JA, Vlassara H.

    Am J Kidney Dis. 2003 Sep;42(3):532-8.PMID: 12955681 [PubMed - indexed for MEDLINE]Related articles

    24.

    Fetal or neonatal low-glycotoxin environment prevents autoimmune diabetes in NOD mice.

    Peppa M, He C, Hattori M, McEvoy R, Zheng F, Vlassara H.

    Diabetes. 2003 Jun;52(6):1441-8.PMID: 12765955 [PubMed - indexed for MEDLINE]Related articlesFree article

    25.

    Advanced glycoxidation. A new risk factor for cardiovascular disease?

    Peppa M, Uribarri J, Vlassara H.

    Cardiovasc Toxicol. 2002;2(4):275-87. Review.PMID: 12665661 [PubMed - indexed for MEDLINE]Related articles

    26.

    Restriction of dietary glycotoxins reduces excessive advanced glycation end products in renal failure patients.

    Uribarri J, Peppa M, Cai W, Goldberg T, Lu M, He C, Vlassara H.

    J Am Soc Nephrol. 2003 Mar;14(3):728-31.PMID: 12595509 [PubMed - indexed for MEDLINE]Related articlesFree article

    27.

    Inflammatory mediators are induced by dietary glycotoxins, a major risk factor for diabetic angiopathy.

    Vlassara H, Cai W, Crandall J, Goldberg T, Oberstein R, Dardaine V, Peppa M, Rayfield EJ.

    Proc Natl Acad Sci U S A. 2002 Nov 26;99(24):15596-601. Epub 2002 Nov 12. Erratum in: Proc Natl Acad Sci U S A. 2003 Jan 21;100(2):763.. PMID: 12429856 [PubMed - indexed for MEDLINE]Related articlesFree article

    28.

    Oxidative stress-inducing carbonyl compounds from common foods: novel mediators of cellular dysfunction.

    Cai W, Gao QD, Zhu L, Peppa M, He C, Vlassara H.

    Mol Med. 2002 Jul;8(7):337-46.PMID: 12393931 [PubMed - indexed for MEDLINE]Related articlesFree article

    29.

    Glycotoxins: a missing link in the "relationship of dietary fat and meat intake in relation to risk of type 2 diabetes in men".

    Peppa M, Goldberg T, Cai W, Rayfield E, Vlassara H.

    Diabetes Care. 2002 Oct;25(10):1898-9. No abstract available. PMID: 12351512 [PubMed - indexed for MEDLINE]Related articlesFree article

    30.

    Maternal expressed emotion and metabolic control of children and adolescents with diabetes mellitus.

    Liakopoulou M, Alifieraki T, Katideniou A, Peppa M, Maniati M, Tzikas D, Hibbs ED, Dacou-Voutetakis C.

    Psychother Psychosom. 2001 Mar-Apr;70(2):78-85.PMID: 11244388 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data

    Search details

    » See more...